There are 3397 resources available
553O - Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of 7 trials
Presenter: Julien Taieb
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
858O - Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
Presenter: Natasha Honoré
Session: Proffered Paper session - Head and neck cancer
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Cancer-related central and peripheral neuropathy
Resources:
Slides
Webcast
Q&A and closing remarks
Presenter: Rosa Giuliani
Session: ESMO-WHO review of innovation in cancer therapeutics: Does the pipeline meet the need?
Resources:
Slides
Webcast
Invited Discussant 858O
Presenter: Jens Peter Klussmann
Session: Proffered Paper session - Head and neck cancer
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Molecular targets and related treatments
Resources:
Slides
Webcast
LBA29 - Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial
Presenter: John Chia
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
1082O - Concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for melanoma (MM) patients (pts) with leptomeningeal disease (LMD)
Presenter: Isabella Glitza
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Conclusions and perspectives
Presenter: Daniel Heinrich
Session: Molecular targets and related treatments
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Head and neck cancer
Resources:
Webcast